Search | IOVS | ARVO Journals

View

Showing 1 – 13 of 13

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2019

Awareness of olfactory impairment in a cohort of patients with CNGB1 -associated retinitis pigmentosa

Farid Afshar; Gavin Arno; Rola Ba-Abbad; Simona Degli Esposti; Michel Michaelides; Andrew Webster; Omar Mahroo

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5423. doi:

ARVO Annual Meeting Abstract July 2019

Visual Outcome Following Intravitreal Anti-VEGF Injection In Eyes With Choroidal Neovascular Membrane Secondary to Chronic Central Serous Chorioretinopathy

Filipa Rodrigues; Hagar Khalid; Farid Afshar; Katrin Fasler; Giuseppe Casalino; Magdy Moussa; Konstantinos Balaskas; Pearse Andrew Keane

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5009. doi:

ARVO Annual Meeting Abstract July 2018

One and two-year visual acuity outcomes after treatment for neovascular age-related macular degeneration at a large tertiary ophthalmic hospital

Katrin Fasler; Farid Afshar; Reena Chopra; Karsten Ulrich Kortuem; Nikolas Pontikos; Siegfried K Wagner; Laxmi Raja; Hasaneen Al Janabi; Thushanthi Ramakrishnan; GABRIELLA CLAIRE PRESTON; Konstantinos Balaskas; Adnan Tufail; Praveen Patel; Pearse Keane

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):826. doi:

ARVO Annual Meeting Abstract July 2018

Visual outcomes after 50 or more intravitreal anti-VEGF injections for neovascular age-related macular degeneration at a large tertiary ophthalmic hospital

Karsten Ulrich Kortuem; Thushanthi Ramakrishnan; Katrin Fasler; Reena Chopra; NIKOLAS PONTIKOS; Siegfried Wagner; Laxmi Raja; Hasaneen Al Janabi; Farid Afshar; Ella Preston; Praveen Patel; Adnan Tufail; Konstantinos Balaskas; Pearse Keane

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):838. doi:

ARVO Annual Meeting Abstract July 2018

Mortality of patients under anti-VEGF therapy at a large tertiary ophthalmic hospital

GABRIELLA CLAIRE PRESTON; NIKOLAS PONTIKOS; Farid Afshar; Reena Chopra; Siegfried K Wagner; Katrin Fasler; Karsten Ulrich Kortuem; Thushanthi Ramakrishnan; Adnan Tufail; Konstantinos Balaskas; Praveen Patel; Pearse Andrew Keane

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1469. doi:

ARVO Annual Meeting Abstract July 2018

Five-year visual acuity outcomes after treatment for neovascular age-related macular degeneration at a large tertiary ophthalmic hospital

Thushanthi Ramakrishnan; Katrin Fasler; Reena Chopra; Karsten Ulrich Kortuem; Nikolas Pontikos; Siegfried K Wagner; Laxmi Raja; Hasaneen Al Janabi; Farid Afshar; GABRIELLA CLAIRE PRESTON; Konstantinos Balaskas; Praveen Patel; Adnan Tufail; Pearse Keane

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1471. doi:

ARVO Annual Meeting Abstract July 2018

Ranibizumab and Aflibercept: Baseline and 12-month visual outcomes of patients at a large tertiary ophthalmic hospital

Siegfried K Wagner; Katrin Fasler; Farid Afshar; Reena Chopra; Karsten Ulrich Kortuem; Nikolas Pontikos; Thushanthi Ramakrishnan; Ella Preston; Praveen Patel; Adnan Tufail; Konstantinos Balaskas; Pearse Andrew Keane

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):815. doi:

ARVO Annual Meeting Abstract July 2018

Development of neovascular age-related macular degeneration in fellow eyes of patients undergoing intravitreal anti-VEGF therapy at a large tertiary ophthalmic hospital

Reena Chopra; Siegfried K Wagner; Katrin Fasler; Karsten Ulrich Kortuem; Nikolas Pontikos; Farid Afshar; Thushanthi Ramakrishnan; GABRIELLA CLAIRE PRESTON; Konstantinos Balaskas; Praveen Patel; Adnan Tufail; Pearse Andrew Keane

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):816. doi:

ARVO Annual Meeting Abstract July 2018

Ethnic differences in presenting characteristics and visual acuity outcomes of neovascular age-related macular degeneration within an urban tertiary ophthalmic hospital

Farid Afshar; Siegfried Wagner; Katrin Fasler; Reena Chopra; Karsten Ulrich Kortuem; Nikolas Pontikos; Thushanthi Ramakrishnan; GABRIELLA CLAIRE PRESTON; Konstantinos Balaskas; Adnan Tufail; Praveen Patel; Pearse Keane

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5550. doi:

ARVO Annual Meeting Abstract September 2016

Two year visual outcomes in patients with neovascular age-related macular degeneration treated with ranibizumab stratified by patient age and baseline visual acuity

Elewys Hearne; Farid Afshar; Emily Fletcher; Quresh Mohamed; Rob Johnston

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):548. doi:

ARVO Annual Meeting Abstract September 2016

Long term visual outcomes in ranibizumab non-responders: patients with neovascular age-related macular degeneration switched from ranibizumab to aflibercept

Farid Afshar; Emily Fletcher; Quresh Mohamed; Rob Johnston

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):520. doi:

ARVO Annual Meeting Abstract March 2012

Scleral Contact Lenses in the Management of Corneal Transplant Patients and Keratoconus

Farid Afshar; Ken Pullum; Linda Ficker

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):4716. doi:

ARVO Annual Meeting Abstract April 2011

Scleral Contact Lenses in the Management of Keratoconus and Corneal Transplant Patients

Farid Afshar; Ken W. Pullum; Linda Ficker

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):6522. doi:

Advertisement